Sort
166,118 grants matching “stem cells”
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$2,074,913Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2023 · CA
NK cells, their receptors and unrelated donor transplant
$2,074,355Jeffrey S Miller · University Of Minnesota · P01 · FY2014 · CA
Neuronal Circuits Controlling Behavior: Genetic Analysis in Zebrafish
$2,074,297Harold Burgess · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease
$2,074,215Soumitra Ghosh · Avexegen Therapeutics, Inc. · R44 · FY2022 · DK
Center for Live Cell Genomics
$2,073,803David H Haussler · University Of California Santa Cruz · RM1 · FY2023 · HG
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
$2,072,934Clotilde Lagier-Tourenne · Massachusetts General Hospital · RM1 · FY2023 · NS
Disease mechanism and therapies for retinal degeneration
$2,072,913Tiansen Li · National Eye Institute · ZIA · FY2016 · EY
Biology & Transplantation of the Human Stem Cell
$2,072,348Philip McGlave · University Of Minnesota · P01 · FY2006 · CA
Vascular remodeling in patients with rare genetic disorders
$2,072,321Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Normal and Neoplastic Growth in the Brain
$2,072,072Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2016 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$2,071,892Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Integrated Mechanisms of Cardiac Maladaptation
$2,071,418R John Solaro · University Of Illinois At Chicago · P01 · FY2020 · HL
Adaptations to Hypoxia
$2,070,976Kurt R Stenmark · University Of Colorado Denver · P01 · FY2012 · HL
MESENCHYMAL STEM CELL EXTRACELLULAR VESICLE THERAPIES FOR EPIDERMOLYSIS BULLOSA
$2,070,414University Of Miami · · FY2025 · Defense Health Agency
Cellular and Molecular Mechanisms of Atherosclerosis
$2,070,048Alan Richard Tall · Columbia University Health Sciences · P01 · FY2024 · HL
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical Research
$2,070,000Lingjun Li · University Of Wisconsin-Madison · S10 · FY2011 · RR
Structural Cell Biology Core
$2,069,421John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2007 · CA
Gene Therapy for Hemophilia
$2,069,413Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2012 · HL
Central Nervous System Drug Delivery Techniques
$2,068,109Russell Lonser · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Gene Therapy for Sickle Cell Disease
$2,067,487St. Jude Children'S Research Hospital · P01 · FY2004 · HL
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury
$2,067,432Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2025 · HL
SPORE in Brain Cancer
$2,067,370Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Targeted Bone Regeneration via Activation of Resident Stem Cells
$2,066,904Tracey Rogers · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Protein-mediated membrane remodeling
$2,066,193Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Biology & Transplantation of the Human Stem Cell
$2,065,942Philip McGlave · University Of Minnesota · P01 · FY2007 · CA